Boston Scientific Corporation
Boston Scientific Corporation is a world leader in developing, manufacturing, and marketing medical devices, with key expertise in interventional cardiology and peripheral vascular interventions. Founded in 1979 in Watertown, Massachusetts, the company’s headquarters are now in Marlborough, Massachusetts. Boston Scientific continuously builds its portfolio through strategic acquisitions, such as BTG International and Claret Medical, to strengthen its presence in vascular devices. This growth strategy aims to provide comprehensive solutions for the entire continuum of vascular conditions. The company provides an extensive portfolio of pioneering products designed to treat diseases of the peripheral vascular system, excluding those of the heart and brain. Its PVD product line includes drug-eluting stents, atherectomy systems, embolic protection devices, guidewires, catheters, and balloon dilation devices. Notable products include the Eluvia Drug-Eluting Vascular Stent System, the ROTAPRO Rotational Atherectomy System, and the Mustang PTA Balloon Catheter. These devices are applied to complex cases diagnosed with Peripheral Arterial Disease (PAD) and Chronic Limb-Threatening Ischemia (CLI), enabling physicians to improve patient outcomes through minimally invasive technologies.
Latest Market Research Report on Peripheral Vascular Devices Download PDF Brochure Now
Medtronic
Medtronic plc is a globally operating medical device industry company, founded in Minneapolis in 1949 and now headquartered in Dublin, Ireland. The company is a key developer and manufacturer of healthcare technologies and therapies, operating in over 150 countries. Medtronic’s focus is on developing technologies that address significant healthcare challenges through a broad range of products that improve the lives of patients worldwide. Medtronic is a major player in the peripheral vascular devices market, offering a comprehensive suite of products designed to treat peripheral arterial disease (PAD) and venous disease. Its portfolio includes innovative technologies such as the HawkOne™ and SilverHawk™ directional atherectomy systems for plaque removal, and the Abre™ venous self-expanding stent system designed for the unique challenges of venous disease. Additionally, Medtronic provides a full range of specialty and high-pressure PTA balloon catheters, including the Chocolate™* and Admiral Xtreme™ systems, along with various peripheral stents and cardiovascular guidewires for interventional procedures.
Abbott Laboratories
Abbott Laboratories is a well-established American medical device and healthcare company, founded in 1888. Headquartered in Abbott Park, Illinois, the company has an extensive global presence and a diverse product line that includes medical devices, branded generic medicines, and nutritional products. Abbott is renowned for its commitment to innovation in vascular solutions, addressing a wide array of complex health issues with advanced technology. Abbott stands at the forefront of the peripheral vascular devices market, leveraging a robust research and development pipeline to create innovative vascular solutions. The company’s offerings include advanced bare metal and drug-eluting stents, as well as next-generation vascular imaging systems that facilitate safer and highly effective minimally invasive interventions. A significant recent advancement is the FDA approval for the Esprit BTK Everolimus Eluting Resorbable Scaffold System, a dissolvable stent designed for chronic limb-threatening ischemia below the knee. This focus on bioresorbable technology highlights Abbott’s continuous push toward patient-centric, evolving healthcare solutions.
Becton, Dickinson and Company (BD)
Becton, Dickinson and Company, or BD, is a major global medical technology company involved in the development, manufacture, and distribution of medical devices, laboratory equipment, and diagnostic products. With a strong presence across 61 countries, BD operates through three main business segments: BD Medical, BD Life Sciences, and BD Interventional, which collectively support a wide range of healthcare settings. BD holds a strong position in the peripheral vascular devices market, particularly in the vascular access device segment. Through its BD Medical and BD Interventional units, the company offers a comprehensive portfolio that includes Peripherally Inserted Central Catheters (PICCs), Peripheral Intravenous Catheters (PIVCs), central venous catheters, and specialized chronic dialysis catheters and ports. By offering these high-quality, minimally invasive solutions, BD aims to optimize clinical workflows, enhance procedural safety, and improve overall patient outcomes across various vascular interventions and complex procedures.
Koninklijke Philips N.V. (Philips)
Koninklijke Philips N.V., commonly known as Royal Philips, is a global technology company headquartered in the Netherlands, with a major focus on health technology. Through its Connected Care segment, Philips provides integrated patient monitoring platforms and digital health solutions designed to create a seamless care experience across hospitals and homes. The company strategically invests in R&D and key partnerships to advance its market presence in patient-centric care. Philips contributes to the peripheral vascular devices market by developing integrated interventional tools and diagnostic platforms. A key area of their innovation is the development of advanced catheter-based technologies to treat Peripheral Artery Disease (PAD). For instance, in a recent clinical trial, Philips is evaluating a groundbreaking catheter that combines laser atherectomy—a procedure to remove plaque—with intravascular lithotripsy (IVL) to treat heavily calcified lesions. This focus on combining treatment modalities reflects Philips’ commitment to delivering technologically advanced, minimally invasive solutions that aim to simplify complex PAD interventions and improve clinical results.
Terumo Corporation
Terumo Corporation is a Tokyo, Japan-based global medical device company, recognized for its excellence in cardiovascular and vascular care concepts. Founded in 1921, the company’s extensive offerings span from minimally invasive technologies to advanced therapeutic systems, aimed at aiding physicians in efforts to improve patient outcomes globally. Terumo operates through specialized subsidiaries, which complement its strong presence in various medical markets. Terumo is a significant provider of peripheral vascular devices, concentrating on the treatment of conditions such as Peripheral Artery Disease (PAD) and Deep Vein Thrombosis (DVT), as well as other arterial and venous conditions outside the heart and brain. Their product portfolio includes various peripheral stents, drug-eluting stents, and guidewires. The company’s subsidiary, Terumo Interventional Systems (TIS), is integral to this market, actively developing technologies for vascular access, embolization, and peripheral vascular interventions, supporting physicians with tools to minimize complications during procedures.
Latest Market Research Report on Peripheral Vascular Devices Download PDF Brochure Now